PRKN and Parkinson disease: The compound heterozygous (c.8_171del/c.535_871del, p.V3EfsX3/p.G179LfsX7) mutation carrier had not developed PD by her seventh decade despite a complete loss of functional Parkin (Koentjoro et al., 2012).